JULY EDITION

In Conversation with OPEN Health

National Institute for Health and Care Excellence (NICE) and Food and Drug Administration (FDA) Real-World Evidence (RWE) guidelines: Practical Takeaways

Both UK and US authorities have shown interest and acceptance of RWE being used in generating medical evidence. As with all evidence, it must adhere to high quality standards before implementation. But what are those standards? RWE is not entirely novel, but it’s use and promise also causes substantial confusion across pharmaceutical and biotech companies, consultancies, and regulatory institutions.

This talk will deep-dive into practical takeaways from current US and UK guidelines that can be adopted across multiple stakeholders.